Related Experiment Video

Updated: May 16, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

[Synthesis and anti-tumor properties of myelopeptide MP-1]

L A Fonina, E M Treshchalina, R G Belevskaia

    Bioorganicheskaia Khimiia
    |November 30, 2012
    PubMed

    Insights

    Bone marrow peptide MP-1 shows anti-tumor effects. It enhances chemotherapy for leukemia and reduces metastasis in breast cancer models.

    Area of Science:

    • Biochemistry
    • Peptide Synthesis
    • Oncology

    Context:

    • Bone marrow-derived peptides represent a novel class of therapeutic agents.
    • The peptide Phe-Leu-Gly-Phe-Pro-Thr (MP-1) was synthesized using established chemical methods.
    • Investigating the anti-tumor potential of MP-1 is crucial for developing new cancer therapies.

    Purpose:

    • To evaluate the anti-tumor properties of the synthesized peptide MP-1.
    • To determine MP-1's efficacy in combination with cytostatic therapy for lymphatic leukemia P388.
    • To assess MP-1's impact on tumor growth and metastasis in preclinical cancer models.

    Summary:

    • MP-1 demonstrated enhanced efficacy when combined with cytostatic therapy for lymphatic leukemia P388.
    • Administration of MP-1 led to an increased latent growth period for P388 tumors in irradiated mice.
    • MP-1 significantly reduced the incidence of metastasis in mouse breast adenocarcinoma Ca-755 following surgical intervention.

    Impact:

    • MP-1 exhibits potential as an adjunct therapy to improve outcomes in leukemia treatment.
    • The peptide shows promise in controlling tumor progression and preventing metastasis in solid tumors.
    • These findings support further research into MP-1 as a novel anti-cancer agent.

    More Related Videos

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...